Prostate Cancer Screening:
On this page you will learn more about prostate cancer screening. You will also learn about the risks and benefits of screening.
Screening is used to look for cancer before you have any symptoms or signs. When cancer is first detected, it is usually in the early stages. This means that there is a greater likelihood of successful treatment of cancer. Scientists have developed and continue to develop tests that can be used to screen people for certain types of cancer. The overall goals of cancer screening are:
- Reduce the number of people dying from the disease or completely eliminate cancer deaths.
- Reduce the number of people suffering from prostate cancer.
Screening For Prostate Cancer:
Prostate cancer is screened for evidence of cancer in other healthy men. Both tests are commonly used to screen for prostate cancer:
- Digital rectal examination (DRE) The National Comprehensive Cancer Network considers the patient’s age, PSA values, DRE results and other factors in their recommendations.). DRE is a test in which a doctor wears a gloved, lubricated finger into the male rectum. Feels any irregularities on the surface of the prostate through the intestinal wall.
- PSA blood test. There is controversy about using PSA to detect prostate cancer in men without disease symptoms. On the one hand, PSA testing can be used to detect early prostate cancer. Especially in men with many risk factors. Which helps some men get the treatment they need before cancer grows and spreads. On the other hand, in addition to slow-growing prostate cancer. PSA screening also finds diseases that are not cancer, such as BPH, which never threatens men’s lives. Therefore, screening for prostate cancer with PSA may mean that some men undergo surgery. And other treatments that may not be needed. Which can lead to side effects and severely affect the quality of life of men.
ASCO recommends that men without prostate cancer symptoms will not receive PSA screening. If they are expected to live less than 10 years. For men with a life expectancy of more than 10 years. ASCO recommends that they discuss with their doctor to determine if the test is right for them.
Other Organizations Have Different Screening Suggestions:
- The US Preventive Services Task Force (USPSTF) has previously concluded. That the potential risks of PSA screening in healthy men outweigh the potential benefits. The latest USPSTF Final Recommendation Statement on Prostate Cancer Screening states. Men between the ages of 55 and 69 should discuss the pros and cons of PSA screening with their clinicians before making a screening decision. Men aged 70 years and older should not have a routine PSA screening for prostate cancer.
- The American Urological Association and the American Cancer Society recommend that the risks and benefits of male testing be informed before PSA screening occurs. Then make an informed decision in consultation with their physician.
- The National Comprehensive Cancer Network considers the patient’s age, PSA values, DRE results and other factors in their recommendations.
It is not easy to predict which tumors will grow and spread rapidly, and which tumors will grow slowly. Every man should discuss his condition and his personal risk of prostate cancer with his doctor. So they can make an informed decision together.